Signal active
Investment Firm
Overview
Somerset Indus Capital Partners seeks to make private equity and equity-related investments primarily in growth-oriented healthcare companies in India. Somerset is led by Avinash Kenkare on the offshore fund side, a private equity professional with eighteen years of successful investing experience in over fifteen transactions, and duly assisted by Mayur Sirdesai on domestic fund side, a healthcare professional with over twenty years of experience in the Indian Pharma/ Healthcare Industry with both private equity, operational and consulting services related experience.
Highlights
2011
1-10
13
7
1
Seed, Early Stage Venture, Private Equity
Private Equity Firm
Location
Africa
Contact Information
Social
Profile Resume
Somerset Indus Capital Partners, established in 2011 and headquartered in Africa., specializes in Seed, Early Stage Venture, Private Equity investments across Health Care, Medical, Medical Device, Hospital, Food and Beverage, Pharmaceutical, Fitness, Manufacturing, Wellness, Nutrition. The organization boasts a portfolio of 12 investments, with an average round size of $6.2M and 1 successful exits. Their recent investments include Browndove Healthcare, Hexagon Nutrition, Genworks, Zawawi Group, Printmann Group. The highest investment round they participated in was $1.1B. Among their most notable exits are Browndove Healthcare and Hexagon Nutrition. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
13
0
7
1
Investments
13
Annouced Date | Organization Name | Industry | Money Raised |
---|---|---|---|
May 04, 2022 | Genworks | Information Technology | 17.8M |
Apr 25, 2023 | Emil Pharmaceutical | Pharmaceutical | 14.6M |
Feb 13, 2024 | Printmann Group | Manufacturing | null |
Aug 09, 2024 | Genworks | Information Technology | 4.9M |
Exits
1
Funding Timeline
13
0
0
Funding Rounds
13
Somerset Indus Capital Partners has raised 13 rounds. Their latest funding was raised on Aug 09, 2024 from a Venture Round - Genworks round.
Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
---|---|---|---|---|
May 04, 2022 | Venture Round - Genworks | - | 17.8M | - |
Apr 25, 2023 | Private Equity Round - Emil Pharmaceutical | - | 14.6M | - |
Feb 13, 2024 | Private Equity Round - Printmann Group | - | 0 | - |
Aug 09, 2024 | Venture Round - Genworks | - | 4.9M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
Annouced Date | Fund Name | Money Raised |
---|---|---|
May 10, 2013 | OTPPLESS | 1.0M |
May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
N/A
Recent Activity
There is no recent news or activity for this profile.